Active ingredient
Rosuvastatin
CRESTOR is usually prescribed for:
Hypercholesterolemia Type IIa
Dyslipidemia type IIb
Homozygous familial hypercholesterolemia
Cardiovascular prevention
Indications CRESTOR-
Treatment of hypercholesterolemia
Adults, adolescents and children aged 6 years or over with pure hypercholesterolemia (type IIa including heterozygous familial hypercholesterolemia) or mixed dyslipidemia (type IIb) in addition to diet when the response to diet and other non-pharmacological treatments (exercise, weight loss) is not enough.
Adults, adolescents and children aged 6 years or over with homozygous familial hypercholesterolaemia, in addition to diet and other lipid-lowering treatments (including LDL apheresis) or when these treatments are not appropriate.
Prevention of cardiovascular events
Prevention of major cardiovascular events in patients considered to be at high risk of having a first cardiovascular event (see section 5.1) Pharmacodynamic properties, in addition to the correction of other risk factors
No comments:
Post a Comment
اكتب تعليق حول الموضوع